Nanoemulsion

Oncology Pharma Pronounces: Preliminary Feasibility Research of the Nanoemulsion Drug Supply System is Full and Outcomes Have Met the Threshold for Shifting Ahead To the Subsequent Steps of Improvement

SAN FRANCISCO, CA / ACCESSWIRE / June 8, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) – Oncology Pharma, Inc. (“The…

Read More »